LORETTA PACE: Open Payments
NPI 1346005139 · NEW MILFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$296 in 15 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $708 · 2025 $296
Food & beverage: $296
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $71 |
| PFIZER INC. | 3 | $58 |
| Lilly USA, LLC | 2 | $49 |
| Exact Sciences Corporation | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Novo Nordisk Inc | 1 | $22 |
| Astellas Pharma US Inc | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Viatris Specialty LLC | 1 | $14 |
Products named: AIRSUPRA, JARDIANCE, PREVNAR 20, Cologuard Collection Kit, SHINGRIX, Ozempic, Veozah, XIFAXAN.
Industry payments across CT — which companies pay providers there.
